We receive funding from a variety of sources that recognize the value of our high-impact research.
Richard Browne, PhD
Contract Renewal: Clinical Pharmacology Quality Assurance and Quality Control. Richard Browne (Co-Investigator), Gene Morse (Principal Investigator). NIH/National Institute of Allergy and Infectious Disease. $12,754,564. 3/1/2015-2/1/2022.
The metabolomics of neurofilaments, neurodegeneration nexus in Multiple Sclerosis progression. Richard Browne (Co-Investigator). DOD. 7/1/2020-6/1/2023.
Effect of Complex Mixtures of Oxidative Stress and Cognition in Children. Richard Browne (Co-Investigator). NIH/NIEHS. 9/1/2020-6/1/2025.
Mapping Heterogeneous Dopamine Signaling in Subregions of the Olfactory Tubercle and Its Effect on Psychostimulant-induced Behaviors. Jinwoo Park (Principal Investigator). NIH/NIDA. $408,034. 7/1/2018-6/1/2020.
Noradrenergic Modulation of Dopaminergic Neuronal Functions. Jinwoo Park (Principal Investigator). Whitehall Foundation. $225,000. 9/1/2017-8/1/2020.